| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.87 | 0.004 | 0.87 | Aldehyde oxidase inhibitor | 0.199 0.105 CID_154699998 | ||
| 0.828 | 0.008 | 0.828 | Caspase 9 stimulant | 0.821 0.008 CID_154699998 | ||
| 0.701 | 0.002 | 0.701 | Cystathionine beta-synthase inhibitor | 0.645 0.003 CID_154699998 | ||
| 0.721 | 0.027 | 0.767 | Apoptosis agonist | 0.767 0.021 CID_154699998 | CID_154699998 | |
| 0.673 | 0.008 | 0.673 | 12-Lipoxygenase inhibitor | |||
| 0.619 | 0.005 | 0.619 | GABA C receptor rho-3 antagonist | |||
| 0.626 | 0.02 | 0.626 | 15-Lipoxygenase inhibitor | |||
| 0.612 | 0.009 | 0.612 | Caspase 3 stimulant | 0.522 0.017 CID_154699998 | ||
| 0.61 | 0.009 | 0.61 | Lipoxygenase inhibitor | 0.186 0.155 CID_154699998 | ||
| 0.597 | 0.004 | 0.597 | Peroxidase inhibitor | |||
| 0.596 | 0.012 | 0.761 | Antioxidant | 0.761 0.005 CID_154699998 | CID_154699998 | |
| 0.592 | 0.009 | 0.715 | Free radical scavenger | 0.715 0.005 CID_154699998 | CID_154699998 | |
| 0.587 | 0.005 | 0.587 | Topoisomerase II inhibitor | 0.555 0.005 CID_154699998 | ||
| 0.576 | 0.012 | 0.576 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.571 | 0.013 | 0.704 | Histamine release inhibitor | 0.704 0.005 CID_154699998 | CID_154699998 | |
| 0.582 | 0.033 | 0.856 | Transcription factor NF kappa B inhibitor | 0.856 0.009 CID_154699998 | CID_154699998 | |
| 0.551 | 0.019 | 0.611 | 5 Hydroxytryptamine release inhibitor | 0.611 0.009 CID_154699998 | CID_154699998 | |
| 0.517 | 0.004 | 0.517 | Aldehyde dehydrogenase inhibitor | 0.438 0.005 CID_154699998 | ||
| 0.505 | 0.014 | 0.505 | Amyloid beta aggregation inhibitor | 0.342 0.036 CID_154699998 | ||
| 0.491 | 0.007 | 0.718 | Melanin inhibitor | 0.718 0.003 CID_154699998 | CID_154699998 | |
| 0.494 | 0.011 | 0.494 | RNA-directed DNA polymerase inhibitor | 0.449 0.014 CID_154699998 | ||
| 0.474 | 0.011 | 0.474 | Pyruvate kinase inhibitor | 0.17 0.1 CID_154699998 | ||
| 0.463 | 0.005 | 0.463 | 5-Lipoxygenase inhibitor | 0.083 0.077 CID_154699998 | ||
| 0.493 | 0.043 | 0.729 | Antibacterial | 0.729 0.007 CID_154699998 | CID_154699998 | |
| 0.517 | 0.076 | 0.778 | Alpha-glucosidase inhibitor | 0.778 0.021 CID_154699998 | CID_154699998 | |
| 0.446 | 0.009 | 0.766 | Monophenol monooxygenase inhibitor | 0.766 0.003 CID_154699998 | CID_154699998 | |
| 0.448 | 0.012 | 0.448 | Transcription factor STAT inhibitor | 0.239 0.094 CID_154699998 | ||
| 0.452 | 0.02 | 0.524 | Hypoxia-inducible factor 1 alpha inhibitor | 0.524 0.013 CID_154699998 | CID_154699998 | |
| 0.44 | 0.01 | 0.44 | Dual specificity phosphatase inhibitor | 0.128 0.123 CID_154699998 | ||
| 0.437 | 0.008 | 0.764 | Amylase inhibitor | 0.764 0.002 CID_154699998 | CID_154699998 | |
| 0.433 | 0.004 | 0.433 | Topoisomerase II alpha inhibitor | 0.392 0.005 CID_154699998 | ||
| 0.425 | 0.006 | 0.425 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.361 0.011 CID_154699998 | ||
| 0.421 | 0.005 | 0.421 | Heat shock protein 90 alpha antagonist | |||
| 0.411 | 0.003 | 0.411 | Creatine kinase inhibitor | 0.116 0.044 CID_154699998 | ||
| 0.42 | 0.015 | 0.42 | Transcription factor STAT3 inhibitor | 0.268 0.07 CID_154699998 | ||
| 0.425 | 0.023 | 0.462 | DNA damaging | 0.462 0.018 CID_154699998 | CID_154699998 | |
| 0.404 | 0.005 | 0.444 | Neurotrophic factor enhancer | 0.444 0.005 CID_154699998 | CID_154699998 | |
| 0.4 | 0.004 | 0.4 | Heat shock protein 90 antagonist | 0.203 0.037 CID_154699998 | ||
| 0.398 | 0.003 | 0.398 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.118 0.03 CID_154699998 | ||
| 0.388 | 0.004 | 0.388 | Estrogen receptor beta antagonist | 0.091 0.082 CID_154699998 | ||
| 0.376 | 0.005 | 0.564 | Hexokinase inhibitor | 0.564 0.003 CID_154699998 | CID_154699998 | |
| 0.378 | 0.011 | 0.459 | Lipid peroxidase inhibitor | 0.459 0.007 CID_154699998 | CID_154699998 | |
| 0.404 | 0.037 | 0.404 | Aryl hydrocarbon receptor agonist | |||
| 0.37 | 0.005 | 0.37 | Estrogen antagonist | 0.129 0.04 CID_154699998 | ||
| 0.367 | 0.01 | 0.45 | NOS3 expression enhancer | 0.45 0.006 CID_154699998 | CID_154699998 | |
| 0.361 | 0.007 | 0.388 | Topoisomerase I inhibitor | 0.388 0.005 CID_154699998 | CID_154699998 | |
| 0.383 | 0.03 | 0.383 | Superoxide dismutase inhibitor | |||
| 0.363 | 0.01 | 0.363 | MAO A inhibitor | |||
| 0.365 | 0.014 | 0.365 | Mcl-1 antagonist | 0.133 0.108 CID_154699998 | ||
| 0.352 | 0.005 | 0.56 | Xanthine oxidase inhibitor | 0.56 0.003 CID_154699998 | CID_154699998 | |
| 0.353 | 0.007 | 0.353 | NADPH oxidase inhibitor | 0.302 0.012 CID_154699998 | ||
| 0.368 | 0.025 | 0.516 | Interleukin agonist | 0.516 0.008 CID_154699998 | CID_154699998 | |
| 0.369 | 0.026 | 0.524 | DNA synthesis inhibitor | 0.524 0.012 CID_154699998 | CID_154699998 | |
| 0.451 | 0.11 | 0.803 | Antiinflammatory | 0.803 0.015 CID_154699998 | CID_154699998 | |
| 0.41 | 0.074 | 0.41 | Calcium channel L-type activator | |||
| 0.349 | 0.015 | 0.349 | MAO inhibitor | |||
| 0.362 | 0.03 | 0.545 | Nitric oxide antagonist | 0.545 0.013 CID_154699998 | CID_154699998 | |
| 0.34 | 0.009 | 0.34 | DNA intercalator | 0.309 0.011 CID_154699998 | ||
| 0.364 | 0.035 | 0.716 | Hypoglycemic | 0.716 0.005 CID_154699998 | CID_154699998 | |
| 0.381 | 0.052 | 0.381 | Streptokinase A inhibitor | |||
| 0.342 | 0.015 | 0.514 | Interferon gamma antagonist | 0.514 0.005 CID_154699998 | CID_154699998 | |
| 0.34 | 0.013 | 0.509 | Protein kinase stimulant | 0.509 0.004 CID_154699998 | CID_154699998 | |
| 0.326 | 0.004 | 0.326 | Keratolytic | 0.083 0.045 CID_154699998 | ||
| 0.348 | 0.026 | 0.497 | Cyclic AMP phosphodiesterase inhibitor | 0.497 0.007 CID_154699998 | CID_154699998 | |
| 0.323 | 0.005 | 0.323 | Estrogen receptor alpha antagonist | |||
| 0.336 | 0.02 | 0.336 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.315 | 0.007 | 0.315 | Carbonic anhydrase XV inhibitor | |||
| 0.31 | 0.005 | 0.31 | HIV-1 integrase (3'-Processing) inhibitor | 0.154 0.013 CID_154699998 | ||
| 0.313 | 0.009 | 0.314 | Nitric-oxide synthase stimulant | 0.314 0.009 CID_154699998 | CID_154699998 | |
| 0.32 | 0.017 | 0.32 | Tubulin antagonist | |||
| 0.374 | 0.075 | 0.374 | Prostaglandin dehydrogenase inhibitor | |||
| 0.301 | 0.005 | 0.301 | Carbonic anhydrase III inhibitor | 0.197 0.017 CID_154699998 | ||
| 0.301 | 0.006 | 0.301 | Telomerase inhibitor | 0.088 0.039 CID_154699998 | ||
| 0.351 | 0.055 | 0.552 | Apoptosis antagonist | 0.552 0.014 CID_154699998 | CID_154699998 | |
| 0.372 | 0.076 | 0.372 | MAP kinase kinase 6 inhibitor | |||
| 0.356 | 0.062 | 0.643 | Cholesterol antagonist | 0.643 0.013 CID_154699998 | CID_154699998 | |
| 0.335 | 0.042 | 0.465 | Antiamyloidogenic | 0.465 0.019 CID_154699998 | CID_154699998 | |
| 0.296 | 0.006 | 0.296 | Histidine decarboxylase inhibitor | |||
| 0.343 | 0.055 | 0.343 | Calcium channel activator | |||
| 0.297 | 0.01 | 0.405 | Antineoplastic antibiotic | 0.405 0.005 CID_154699998 | CID_154699998 | |
| 0.335 | 0.05 | 0.335 | Sodium/bile acid cotransporter inhibitor | 0.27 0.108 CID_154699998 | ||
| 0.32 | 0.036 | 0.32 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.287 | 0.005 | 0.287 | Beta tubulin antagonist | |||
| 0.282 | 0.003 | 0.282 | DOPA decarboxylase inhibitor | 0.117 0.048 CID_154699998 | ||
| 0.283 | 0.004 | 0.283 | CF transmembrane conductance regulator agonist | 0.22 0.013 CID_154699998 | ||
| 0.28 | 0.005 | 0.28 | HIV-1 integrase (Strand Transfer) inhibitor | 0.139 0.014 CID_154699998 | ||
| 0.29 | 0.021 | 0.29 | Protein-tyrosine phosphatase inhibitor | 0.247 0.032 CID_154699998 | ||
| 0.288 | 0.031 | 0.288 | Dual specificity phosphatase 3 inhibitor | |||
| 0.273 | 0.016 | 0.273 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.286 | 0.031 | 0.398 | DNA methyltransferase I inhibitor | 0.398 0.009 CID_154699998 | CID_154699998 | |
| 0.288 | 0.033 | 0.555 | Hepatoprotectant | 0.555 0.005 CID_154699998 | CID_154699998 | |
| 0.265 | 0.011 | 0.265 | Interleukin 4 antagonist | 0.206 0.021 CID_154699998 | ||
| 0.262 | 0.009 | 0.262 | GABA C receptor rho-2 antagonist | |||
| 0.255 | 0.007 | 0.255 | Alcohol dehydrogenase inhibitor | 0.203 0.012 CID_154699998 | ||
| 0.279 | 0.035 | 0.422 | DNA methylase inhibitor | 0.422 0.009 CID_154699998 | CID_154699998 | |
| 0.252 | 0.008 | 0.692 | Beta glucuronidase inhibitor | 0.692 0.002 CID_154699998 | CID_154699998 | |
| 0.337 | 0.094 | 0.536 | Immunosuppressant | 0.536 0.024 CID_154699998 | CID_154699998 | |
| 0.259 | 0.016 | 0.486 | Alkylator | 0.486 0.005 CID_154699998 | CID_154699998 | |
| 0.249 | 0.006 | 0.372 | Photosensitizer | 0.372 0.003 CID_154699998 | CID_154699998 | |
| 0.256 | 0.015 | 0.256 | Chelator | 0.111 0.063 CID_154699998 | ||
| 0.248 | 0.009 | 0.248 | Toll-Like receptor 2 antagonist | 0.128 0.07 CID_154699998 | ||
| 0.245 | 0.006 | 0.245 | Estrogen agonist | 0.109 0.015 CID_154699998 | ||
| 0.256 | 0.019 | 0.275 | Alkaline phosphatase inhibitor | 0.275 0.015 CID_154699998 | CID_154699998 | |
| 0.242 | 0.005 | 0.242 | Alpha tubulin antagonist | |||
| 0.249 | 0.012 | 0.266 | Mannose-6-phosphate isomerase inhibitor | 0.266 0.009 CID_154699998 | CID_154699998 | |
| 0.249 | 0.014 | 0.409 | ATPase inhibitor | 0.409 0.004 CID_154699998 | CID_154699998 | |
| 0.251 | 0.017 | 0.251 | MAO B inhibitor | |||
| 0.364 | 0.135 | 0.364 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.231 | 0.005 | 0.231 | CDC25A inhibitor | 0.109 0.023 CID_154699998 | ||
| 0.233 | 0.01 | 0.233 | Carbonic anhydrase VI inhibitor | 0.109 0.034 CID_154699998 | ||
| 0.223 | 0.002 | 0.223 | ATP citrate lysase inhibitor | 0.053 0.007 CID_154699998 | ||
| 0.222 | 0.003 | 0.222 | Heat shock protein 90 beta antagonist | |||
| 0.353 | 0.136 | 0.353 | DNA directed DNA polymerase inhibitor | |||
| 0.249 | 0.035 | 0.249 | Insulin sensitizer | 0.243 0.038 CID_154699998 | ||
| 0.258 | 0.045 | 0.42 | Peptidyltransferase inhibitor | 0.42 0.005 CID_154699998 | CID_154699998 | |
| 0.217 | 0.004 | 0.217 | CDC25B inhibitor | 0.081 0.027 CID_154699998 | ||
| 0.298 | 0.089 | 0.479 | Vasodilator, coronary | 0.479 0.019 CID_154699998 | CID_154699998 | |
| 0.228 | 0.021 | 0.228 | Cholesterol synthesis inhibitor | 0.169 0.036 CID_154699998 | ||
| 0.21 | 0.004 | 0.21 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.206 | 0.004 | 0.215 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.215 0.004 CID_154699998 | CID_154699998 | |
| 0.231 | 0.03 | 0.231 | Succinate dehydrogenase inhibitor | |||
| 0.204 | 0.004 | 0.204 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.216 | 0.018 | 0.216 | Farnesoid X receptor antagonist | |||
| 0.219 | 0.02 | 0.219 | Catenin beta inhibitor | |||
| 0.241 | 0.044 | 0.241 | P-glycoprotein inhibitor | 0.22 0.053 CID_154699998 | ||
| 0.216 | 0.02 | 0.216 | Arachidonic acid antagonist | 0.157 0.08 CID_154699998 | ||
| 0.198 | 0.005 | 0.198 | Estrogen receptor beta agonist | 0.084 0.014 CID_154699998 | ||
| 0.274 | 0.081 | 0.389 | Spasmolytic | 0.389 0.042 CID_154699998 | CID_154699998 | |
| 0.257 | 0.067 | 0.773 | Angiogenesis stimulant | 0.773 0.004 CID_154699998 | CID_154699998 | |
| 0.201 | 0.011 | 0.201 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.289 | 0.103 | 0.289 | Vasodilator, peripheral | 0.259 0.121 CID_154699998 | ||
| 0.191 | 0.004 | 0.191 | Ca2+-transporting ATPase inhibitor | 0.186 0.005 CID_154699998 | ||
| 0.286 | 0.101 | 0.286 | Thyroid hormone antagonist | |||
| 0.235 | 0.049 | 0.495 | Non-steroidal antiinflammatory agent | 0.495 0.007 CID_154699998 | CID_154699998 | |
| 0.267 | 0.082 | 0.267 | Insulysin inhibitor | |||
| 0.213 | 0.03 | 0.324 | Alpha-N-acetylglucosaminidase inhibitor | 0.324 0.014 CID_154699998 | CID_154699998 | |
| 0.236 | 0.054 | 0.467 | Platelet adhesion inhibitor | 0.467 0.007 CID_154699998 | CID_154699998 | |
| 0.203 | 0.021 | 0.203 | Antibacterial (Helicobacter pylori) | 0.124 0.075 CID_154699998 | ||
| 0.195 | 0.015 | 0.213 | Carbonic anhydrase XIII inhibitor | 0.213 0.012 CID_154699998 | CID_154699998 | |
| 0.199 | 0.019 | 0.542 | Cyclooxygenase 3 inhibitor | 0.542 0.003 CID_154699998 | CID_154699998 | |
| 0.254 | 0.074 | 0.254 | Gastrin inhibitor | 0.196 0.155 CID_154699998 | ||
| 0.188 | 0.009 | 0.188 | Macrophage migration inhibitory factor inhibitor | |||
| 0.221 | 0.043 | 0.221 | Histone acetyltransferase inhibitor | |||
| 0.213 | 0.036 | 0.213 | Phospholipase C inhibitor | 0.186 0.055 CID_154699998 | ||
| 0.261 | 0.084 | 0.261 | 5 Hydroxytryptamine release stimulant | 0.165 0.159 CID_154699998 | ||
| 0.25 | 0.075 | 0.25 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.187 | 0.013 | 0.559 | AMP-activated protein kinase stimulant | 0.559 0.003 CID_154699998 | CID_154699998 | |
| 0.189 | 0.015 | 0.189 | Breast cancer-resistant protein inhibitor | |||
| 0.182 | 0.009 | 0.182 | Transcription factor STAT6 inhibitor | |||
| 0.277 | 0.105 | 0.694 | Antithrombotic | 0.694 0.009 CID_154699998 | CID_154699998 | |
| 0.2 | 0.029 | 0.205 | Protein-tyrosine phosphatase 1B inhibitor | 0.205 0.028 CID_154699998 | CID_154699998 | |
| 0.186 | 0.016 | 0.186 | GABA C receptor antagonist | |||
| 0.189 | 0.019 | 0.189 | Adenylate cyclase stimulant | 0.138 0.085 CID_154699998 | ||
| 0.203 | 0.033 | 0.203 | Cyclooxygenase 1 inhibitor | 0.138 0.065 CID_154699998 | ||
| 0.174 | 0.005 | 0.174 | Xanthine dehydrogenase inhibitor | 0.092 0.019 CID_154699998 | ||
| 0.18 | 0.012 | 0.191 | Heat shock protein 70 antagonist | 0.191 0.008 CID_154699998 | CID_154699998 | |
| 0.183 | 0.015 | 0.183 | TRPA1 agonist | 0.12 0.059 CID_154699998 | ||
| 0.27 | 0.105 | 0.27 | Thyroid hormone beta antagonist | |||
| 0.198 | 0.034 | 0.198 | Acetylcholinesterase inhibitor | |||
| 0.168 | 0.004 | 0.168 | Topoisomerase II beta inhibitor | 0.131 0.006 CID_154699998 | ||
| 0.318 | 0.155 | 0.318 | DNA polymerase beta inhibitor | |||
| 0.166 | 0.004 | 0.166 | Fatty acid synthase inhibitor | 0.087 0.015 CID_154699998 | ||
| 0.194 | 0.035 | 0.535 | Hemostatic | 0.535 0.004 CID_154699998 | CID_154699998 | |
| 0.169 | 0.011 | 0.169 | Aromatase inhibitor | |||
| 0.169 | 0.012 | 0.18 | Thioredoxin inhibitor | 0.18 0.01 CID_154699998 | CID_154699998 | |
| 0.173 | 0.016 | 0.381 | DNA repair enzyme inhibitor | 0.381 0.003 CID_154699998 | CID_154699998 | |
| 0.187 | 0.032 | 0.197 | DNA polymerase I inhibitor | 0.197 0.029 CID_154699998 | CID_154699998 | |
| 0.168 | 0.015 | 0.168 | GABA C receptor rho-1 antagonist | |||
| 0.165 | 0.011 | 0.165 | Anabolic | 0.105 0.056 CID_154699998 | ||
| 0.158 | 0.005 | 0.158 | Estrogen receptor alpha agonist | |||
| 0.162 | 0.011 | 0.162 | Glutamate decarboxylase inhibitor | |||
| 0.158 | 0.008 | 0.158 | Thioredoxin reductase inhibitor | 0.091 0.039 CID_154699998 | ||
| 0.185 | 0.037 | 0.38 | Cell wall synthesis inhibitor | 0.38 0.007 CID_154699998 | CID_154699998 | |
| 0.167 | 0.021 | 0.167 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.22 | 0.074 | 0.22 | Interleukin antagonist | |||
| 0.149 | 0.003 | 0.149 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.244 | 0.099 | 0.532 | Immunostimulant | 0.532 0.025 CID_154699998 | CID_154699998 | |
| 0.162 | 0.018 | 0.162 | Porphobilinogen synthase inhibitor | |||
| 0.196 | 0.056 | 0.196 | Tumour necrosis factor antagonist | |||
| 0.156 | 0.02 | 0.156 | Urease inhibitor | |||
| 0.168 | 0.034 | 0.168 | MAP kinase kinase 4 inhibitor | |||
| 0.152 | 0.02 | 0.152 | Electron transport complex I inhibitor | 0.098 0.087 CID_154699998 | ||
| 0.159 | 0.027 | 0.159 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.136 | 0.004 | 0.136 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.153 | 0.022 | 0.199 | Uric acid excretion stimulant | 0.199 0.013 CID_154699998 | CID_154699998 | |
| 0.209 | 0.079 | 0.209 | Antimitotic | |||
| 0.158 | 0.028 | 0.169 | Mucolytic | 0.169 0.023 CID_154699998 | CID_154699998 | |
| 0.139 | 0.01 | 0.139 | GABA aminotransferase inhibitor | 0.124 0.014 CID_154699998 | ||
| 0.139 | 0.01 | 0.139 | HIV-1 integrase inhibitor | 0.074 0.043 CID_154699998 | ||
| 0.152 | 0.024 | 0.156 | Multidrug resistance-associated protein 1 inhibitor | 0.156 0.023 CID_154699998 | CID_154699998 | |
| 0.155 | 0.027 | 0.351 | UDP-glucose 4-epimerase inhibitor | 0.351 0.008 CID_154699998 | CID_154699998 | |
| 0.16 | 0.032 | 0.473 | Expectorant | 0.473 0.004 CID_154699998 | CID_154699998 | |
| 0.219 | 0.093 | 0.472 | Tumour necrosis factor alpha release inhibitor | 0.472 0.017 CID_154699998 | CID_154699998 | |
| 0.171 | 0.045 | 0.171 | Bone formation stimulant | 0.141 0.067 CID_154699998 | ||
| 0.157 | 0.032 | 0.157 | Vanilloid 1 agonist | 0.148 0.04 CID_154699998 | ||
| 0.177 | 0.053 | 0.177 | Neurotensin receptor agonist | |||
| 0.136 | 0.012 | 0.136 | TRPA1 antagonist | |||
| 0.136 | 0.012 | 0.149 | Aldose reductase inhibitor | 0.149 0.011 CID_154699998 | CID_154699998 | |
| 0.131 | 0.009 | 0.131 | D-Ala-D-Ala ligase inhibitor | |||
| 0.145 | 0.024 | 0.145 | Prolactin inhibitor | |||
| 0.133 | 0.012 | 0.133 | Alcohol oxidase inhibitor | |||
| 0.187 | 0.066 | 0.187 | Amyloid beta precursor protein antagonist | |||
| 0.144 | 0.024 | 0.144 | Androgen antagonist | |||
| 0.141 | 0.023 | 0.252 | Triose-phosphate isomerase inhibitor | 0.252 0.007 CID_154699998 | CID_154699998 | |
| 0.167 | 0.05 | 0.167 | Cytokine production inhibitor | |||
| 0.145 | 0.029 | 0.145 | Potassium channel (Ca-activated) activator | |||
| 0.119 | 0.005 | 0.119 | MAP kinase kinase 7 inhibitor | |||
| 0.117 | 0.004 | 0.117 | Transcription factor RelA inhibitor | |||
| 0.126 | 0.015 | 0.126 | Leukotriene synthesis inhibitor | |||
| 0.209 | 0.098 | 0.375 | Vasodilator | 0.375 0.028 CID_154699998 | CID_154699998 | |
| 0.145 | 0.036 | 0.145 | GABA C receptor agonist | |||
| 0.119 | 0.01 | 0.119 | Estrogen-related receptor beta agonist | |||
| 0.131 | 0.023 | 0.243 | NADH dehydrogenase inhibitor | 0.243 0.008 CID_154699998 | CID_154699998 | |
| 0.13 | 0.025 | 0.13 | Cathepsin G inhibitor | |||
| 0.15 | 0.045 | 0.15 | Adenylate cyclase inhibitor | |||
| 0.126 | 0.021 | 0.126 | Glutamate dehydrogenase inhibitor | 0.082 0.043 CID_154699998 | ||
| 0.145 | 0.04 | 0.189 | Microtubule formation inhibitor | 0.189 0.022 CID_154699998 | CID_154699998 | |
| 0.138 | 0.034 | 0.388 | Mediator release inhibitor | 0.388 0.005 CID_154699998 | CID_154699998 | |
| 0.196 | 0.094 | 0.196 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.163 | 0.061 | 0.163 | Cyclooxygenase inhibitor | 0.124 0.094 CID_154699998 | ||
| 0.196 | 0.095 | 0.196 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.183 | 0.085 | 0.183 | Anesthetic general | 0.173 0.092 CID_154699998 | ||
| 0.143 | 0.046 | 0.143 | Protein kinase (CK2) alpha inhibitor | |||
| 0.139 | 0.043 | 0.139 | Ferrochelatase inhibitor | |||
| 0.16 | 0.066 | 0.16 | Phospholipase A2 inhibitor | 0.138 0.089 CID_154699998 | ||
| 0.116 | 0.023 | 0.116 | Purinergic P2X2 antagonist | |||
| 0.116 | 0.023 | 0.116 | Bile acid receptor antagonist | |||
| 0.18 | 0.092 | 0.184 | Psychostimulant | 0.184 0.09 CID_154699998 | CID_154699998 | |
| 0.118 | 0.032 | 0.118 | ABCA1 expression enhancer | |||
| 0.105 | 0.02 | 0.13 | T cell inhibitor | 0.13 0.012 CID_154699998 | CID_154699998 | |
| 0.117 | 0.035 | 0.117 | Protein kinase C zeta inhibitor | |||
| 0.11 | 0.028 | 0.14 | ATPase (Vacuolar H+) inhibitor | 0.14 0.01 CID_154699998 | CID_154699998 | |
| 0.175 | 0.095 | 0.175 | I kappa B kinase epsilon inhibitor | |||
| 0.097 | 0.017 | 0.097 | Carbonic anhydrase VB inhibitor | |||
| 0.114 | 0.035 | 0.135 | Interleukin 12 antagonist | 0.135 0.018 CID_154699998 | CID_154699998 | |
| 0.087 | 0.009 | 0.087 | DNA helicase inhibitor | 0.062 0.026 CID_154699998 | ||
| 0.109 | 0.031 | 0.109 | CYP2A6 inhibitor | |||
| 0.137 | 0.061 | 0.137 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.094 | 0.018 | 0.094 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.095 | 0.02 | 0.095 | GABA B receptor agonist | |||
| 0.109 | 0.035 | 0.109 | Ornithine decarboxylase inhibitor | 0.086 0.061 CID_154699998 | ||
| 0.144 | 0.071 | 0.144 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.098 | 0.026 | 0.098 | Carbonic anhydrase VA inhibitor | |||
| 0.099 | 0.027 | 0.099 | Carbonic anhydrase V inhibitor | |||
| 0.136 | 0.065 | 0.136 | Cyclooxygenase 2 inhibitor | 0.103 0.101 CID_154699998 | ||
| 0.089 | 0.02 | 0.089 | Purinergic P2X1 antagonist | |||
| 0.128 | 0.059 | 0.128 | Proteasome inhibitor | |||
| 0.122 | 0.054 | 0.122 | 5 Hydroxytryptamine 3A agonist | |||
| 0.099 | 0.032 | 0.121 | Na+ K+ transporting ATPase inhibitor | 0.121 0.015 CID_154699998 | CID_154699998 | |
| 0.078 | 0.012 | 0.078 | Dihydroorotate oxidase inhibitor | |||
| 0.095 | 0.03 | 0.095 | Cyclin B3 inhibitor | |||
| 0.074 | 0.008 | 0.074 | Retinoid X alpha receptor agonist | |||
| 0.08 | 0.015 | 0.08 | Heme oxygenase stimulant | 0.06 0.046 CID_154699998 | ||
| 0.123 | 0.06 | 0.123 | Interleukin 1b antagonist | |||
| 0.156 | 0.093 | 0.156 | Death-associated protein kinase 2 inhibitor | |||
| 0.073 | 0.011 | 0.073 | Pregnane X receptor antagonist | |||
| 0.152 | 0.091 | 0.152 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.069 | 0.007 | 0.069 | DNA gyrase subunit A inhibitor | 0.047 0.02 CID_154699998 | ||
| 0.175 | 0.114 | 0.175 | Dyrk kinase inhibitor | |||
| 0.101 | 0.04 | 0.101 | Interleukin 5 antagonist | 0.098 0.043 CID_154699998 | ||
| 0.069 | 0.009 | 0.069 | Dopamine D5 agonist | |||
| 0.138 | 0.078 | 0.138 | Pregnane X receptor agonist | |||
| 0.134 | 0.075 | 0.134 | Neurotrophic factor | 0.122 0.092 CID_154699998 | ||
| 0.13 | 0.072 | 0.13 | Toll-Like receptor antagonist | |||
| 0.063 | 0.004 | 0.063 | Estrogen-related receptor beta antagonist | |||
| 0.132 | 0.073 | 0.132 | Interleukin 1 antagonist | |||
| 0.089 | 0.032 | 0.089 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.141 | 0.084 | 0.32 | Insulin secretagoues | 0.32 0.01 CID_154699998 | CID_154699998 | |
| 0.062 | 0.006 | 0.092 | Protein 30S ribosomal subunit inhibitor | 0.092 0.003 CID_154699998 | CID_154699998 | |
| 0.081 | 0.025 | 0.081 | Aryl hydrocarbon receptor antagonist | |||
| 0.067 | 0.011 | 0.067 | Retinoid X receptor agonist | |||
| 0.194 | 0.139 | 0.194 | MAP kinase kinase 3 inhibitor | |||
| 0.11 | 0.055 | 0.11 | Protein kinase (CK2) inhibitor | |||
| 0.079 | 0.025 | 0.079 | Androgen agonist | |||
| 0.06 | 0.007 | 0.06 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.095 | 0.042 | 0.095 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.075 | 0.023 | 0.075 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.099 | 0.048 | 0.099 | NMDA receptor antagonist | |||
| 0.243 | 0.192 | 0.243 | Transcription factor inhibitor | |||
| 0.152 | 0.102 | 0.152 | Lipocortins synthesis antagonist | 0.14 0.121 CID_154699998 | ||
| 0.116 | 0.066 | 0.116 | Interleukin 8 antagonist | |||
| 0.079 | 0.029 | 0.079 | Glutamate (mGluR7) antagonist | |||
| 0.141 | 0.092 | 0.141 | Sigma receptor agonist | |||
| 0.056 | 0.007 | 0.056 | Catechol O-methyltransferase inhibitor | |||
| 0.105 | 0.06 | 0.105 | Adenylate kinase inhibitor | |||
| 0.081 | 0.037 | 0.081 | Glycine receptor agonist | 0.075 0.046 CID_154699998 | ||
| 0.071 | 0.027 | 0.071 | Cyclin D1 inhibitor | |||
| 0.066 | 0.022 | 0.111 | Leukotriene B4 antagonist | 0.111 0.008 CID_154699998 | CID_154699998 | |
| 0.083 | 0.04 | 0.172 | Phosphofructokinase-1 inhibitor | 0.172 0.014 CID_154699998 | CID_154699998 | |
| 0.06 | 0.018 | 0.06 | Adenylate cyclase 1 inhibitor | |||
| 0.056 | 0.015 | 0.062 | Guanylate cyclase inhibitor | 0.062 0.01 CID_154699998 | CID_154699998 | |
| 0.061 | 0.02 | 0.061 | CD45 antagonist | |||
| 0.045 | 0.005 | 0.045 | Thyroid hormone agonist | |||
| 0.086 | 0.046 | 0.086 | CC chemokine 5 receptor agonist | |||
| 0.108 | 0.069 | 0.109 | Acetylcholine release stimulant | 0.109 0.068 CID_154699998 | CID_154699998 | |
| 0.059 | 0.021 | 0.059 | Squalene epoxidase inhibitor | |||
| 0.058 | 0.021 | 0.058 | Carbonic anhydrase VII inhibitor | |||
| 0.125 | 0.089 | 0.157 | CC chemokine 6 receptor antagonist | 0.157 0.015 CID_154699998 | CID_154699998 | |
| 0.074 | 0.04 | 0.074 | Potassium channel large-conductance Ca-activated activator | |||
| 0.13 | 0.096 | 0.13 | Cholinergic | |||
| 0.201 | 0.168 | 0.347 | Angiogenesis inhibitor | 0.347 0.072 CID_154699998 | CID_154699998 | |
| 0.067 | 0.034 | 0.067 | Biliverdin reductase inhibitor | |||
| 0.087 | 0.053 | 0.087 | Vanilloid agonist | |||
| 0.058 | 0.025 | 0.058 | CXC chemokine 1 receptor antagonist | |||
| 0.087 | 0.054 | 0.087 | Myeloperoxidase inhibitor | |||
| 0.152 | 0.119 | 0.152 | MAP kinase kinase 2 inhibitor | |||
| 0.072 | 0.039 | 0.072 | Leukotriene antagonist | 0.07 0.04 CID_154699998 | ||
| 0.045 | 0.013 | 0.045 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.067 | 0.035 | 0.067 | Calcium channel P-type blocker | |||
| 0.085 | 0.054 | 0.085 | Inducible nitric-oxide synthase inhibitor | |||
| 0.063 | 0.033 | 0.063 | Maillard reaction inhibitor | |||
| 0.06 | 0.029 | 0.079 | Adenine nucleotide translocase inhibitor | 0.079 0.009 CID_154699998 | CID_154699998 | |
| 0.046 | 0.016 | 0.046 | Retinoid X receptor antagonist | |||
| 0.035 | 0.006 | 0.059 | Vanilloid 2 agonist | 0.059 0.002 CID_154699998 | CID_154699998 | |
| 0.049 | 0.02 | 0.049 | Liver X receptor alpha agonist | |||
| 0.09 | 0.061 | 0.096 | Glutamate release inhibitor | 0.096 0.049 CID_154699998 | CID_154699998 | |
| 0.032 | 0.003 | 0.054 | Antibiotic Anthracycline-like | 0.054 0.001 CID_154699998 | CID_154699998 | |
| 0.076 | 0.048 | 0.12 | Histone deacetylase SIRT1 stimulant | 0.12 0.018 CID_154699998 | CID_154699998 | |
| 0.076 | 0.048 | 0.12 | Histone deacetylase stimulant | 0.12 0.018 CID_154699998 | CID_154699998 | |
| 0.073 | 0.045 | 0.073 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.053 | 0.025 | 0.072 | Glucose-6-phosphate isomerase inhibitor | 0.072 0.011 CID_154699998 | CID_154699998 | |
| 0.058 | 0.031 | 0.058 | Cannabinoid CB2 receptor antagonist | |||
| 0.081 | 0.054 | 0.126 | Glycine receptor antagonist | 0.126 0.015 CID_154699998 | CID_154699998 | |
| 0.029 | 0.002 | 0.029 | Antibiotic Tetracycline-like | 0.02 0.004 CID_154699998 | ||
| 0.065 | 0.039 | 0.065 | NMDA 2C receptor antagonist | |||
| 0.091 | 0.065 | 0.113 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.113 0.043 CID_154699998 | CID_154699998 | |
| 0.061 | 0.035 | 0.061 | Ryanodine receptor antagonist | |||
| 0.093 | 0.068 | 0.134 | Phosphodiesterase 6D inhibitor | 0.134 0.015 CID_154699998 | CID_154699998 | |
| 0.052 | 0.027 | 0.052 | Aldosterone antagonist | |||
| 0.058 | 0.034 | 0.058 | 5 Hydroxytryptamine 7 agonist | |||
| 0.061 | 0.037 | 0.061 | Bcl-xL inhibitor | |||
| 0.048 | 0.025 | 0.048 | Leukocyte elastase inhibitor | |||
| 0.092 | 0.069 | 0.092 | Butyrylcholinesterase inhibitor | |||
| 0.038 | 0.015 | 0.038 | Protein kinase (CK2) beta inhibitor | |||
| 0.033 | 0.011 | 0.124 | Sodium/glucose cotransporter 2 inhibitor | 0.124 0.002 CID_154699998 | CID_154699998 | |
| 0.068 | 0.047 | 0.068 | Exportin-1 inhibitor | |||
| 0.03 | 0.009 | 0.03 | Leukotriene B4 receptor 2 antagonist | 0.03 0.008 CID_154699998 | ||
| 0.054 | 0.034 | 0.054 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.072 | 0.051 | 0.072 | Aminopeptidase I inhibitor | |||
| 0.065 | 0.046 | 0.065 | Beta adrenoreceptor antagonist | |||
| 0.038 | 0.019 | 0.038 | Estrogen-related receptor alpha antagonist | |||
| 0.062 | 0.042 | 0.07 | Transcription factor AP-1 inhibitor | 0.07 0.03 CID_154699998 | CID_154699998 | |
| 0.059 | 0.04 | 0.059 | Sphingosine kinase inhibitor | |||
| 0.046 | 0.028 | 0.046 | NMDA receptor subunit 3B antagonist | |||
| 0.032 | 0.013 | 0.032 | Estrogen-related receptor gamma antagonist | |||
| 0.066 | 0.048 | 0.066 | Glutamate (mGluR6) antagonist | |||
| 0.042 | 0.024 | 0.042 | NMDA receptor subunit 3A antagonist | |||
| 0.029 | 0.012 | 0.121 | Sodium/glucose cotransporter inhibitor | 0.121 0.002 CID_154699998 | CID_154699998 | |
| 0.041 | 0.025 | 0.041 | Urate transporter 1 inhibitor | |||
| 0.133 | 0.117 | 0.133 | LIM domain kinase 1 inhibitor | |||
| 0.04 | 0.025 | 0.04 | Retinoic acid alpha receptor agonist | |||
| 0.051 | 0.037 | 0.051 | NMDA 2A receptor antagonist | |||
| 0.048 | 0.035 | 0.087 | Carbonic anhydrase XIV inhibitor | 0.087 0.014 CID_154699998 | CID_154699998 | |
| 0.083 | 0.07 | 0.083 | Bromodomain-containing protein 2 inhibitor | |||
| 0.201 | 0.188 | 0.424 | Interleukin 2 agonist | 0.424 0.021 CID_154699998 | CID_154699998 | |
| 0.096 | 0.084 | 0.096 | Protein kinase C gamma inhibitor | |||
| 0.035 | 0.022 | 0.035 | Purinergic P2Y2 antagonist | |||
| 0.038 | 0.025 | 0.038 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.071 | 0.059 | 0.078 | Phosphodiesterase VI inhibitor | 0.078 0.045 CID_154699998 | CID_154699998 | |
| 0.132 | 0.12 | 0.235 | Interleukin 6 antagonist | 0.235 0.026 CID_154699998 | CID_154699998 | |
| 0.025 | 0.014 | 0.025 | CYP24 inhibitor | |||
| 0.032 | 0.022 | 0.032 | Glutamate (mGluR3) agonist | |||
| 0.04 | 0.029 | 0.04 | Cathepsin L2 inhibitor | |||
| 0.024 | 0.013 | 0.024 | Glutamate (mGluR1a) agonist | |||
| 0.053 | 0.043 | 0.053 | Argininosuccinate synthase inhibitor | |||
| 0.046 | 0.036 | 0.046 | Cholesterol esterase inhibitor | |||
| 0.199 | 0.189 | 0.199 | Calpain 2 inhibitor | |||
| 0.06 | 0.05 | 0.06 | Dopamine D1 antagonist | |||
| 0.043 | 0.033 | 0.043 | Dihydroorotase inhibitor | |||
| 0.034 | 0.025 | 0.034 | Adenosine uptake inhibitor | |||
| 0.19 | 0.181 | 0.19 | Thioredoxin glutathione reductase inhibitor | |||
| 0.044 | 0.035 | 0.044 | Purinergic P2X4 antagonist | |||
| 0.048 | 0.039 | 0.048 | Beta 2 adrenoreceptor antagonist | |||
| 0.1 | 0.091 | 0.1 | Caspase 3 inhibitor | |||
| 0.13 | 0.122 | 0.13 | Antipruritic | |||
| 0.076 | 0.068 | 0.076 | Glutathione S-transferase inhibitor | |||
| 0.067 | 0.059 | 0.067 | Phospholipase D inhibitor | |||
| 0.108 | 0.1 | 0.108 | Toll-Like receptor 9 antagonist | |||
| 0.033 | 0.025 | 0.033 | Retinoid X alpha receptor antagonist | |||
| 0.034 | 0.026 | 0.034 | Progesterone antagonist | |||
| 0.012 | 0.005 | 0.012 | Thyroid hormone beta agonist | |||
| 0.044 | 0.037 | 0.044 | Potassium channel Kv1.3 blocker | |||
| 0.06 | 0.054 | 0.118 | Neuraminidase (influenza) inhibitor | 0.118 0.012 CID_154699998 | CID_154699998 | |
| 0.05 | 0.043 | 0.05 | Human rhinovirus A protease inhibitor | |||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.055 | 0.049 | 0.055 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.121 | 0.116 | 0.121 | Thiol protease inhibitor | |||
| 0.051 | 0.047 | 0.054 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.054 0.042 CID_154699998 | CID_154699998 | |
| 0.018 | 0.014 | 0.018 | Estrogen-related receptor gamma agonist | |||
| 0.035 | 0.031 | 0.035 | Delayed rectifier potassium channel blocker | |||
| 0.064 | 0.06 | 0.064 | Protein kinase C beta inhibitor | |||
| 0.042 | 0.038 | 0.042 | Thymidylate synthase inhibitor | |||
| 0.02 | 0.017 | 0.02 | Estrone sulfatase inhibitor | |||
| 0.016 | 0.013 | 0.016 | Thyroid hormone alpha agonist | |||
| 0.053 | 0.051 | 0.053 | Leukotriene C antagonist | |||
| 0.025 | 0.022 | 0.025 | Leukotriene B4 receptor 1 antagonist | 0.025 0.022 CID_154699998 | ||
| 0.05 | 0.048 | 0.05 | Sphingosine kinase 2 inhibitor | |||
| 0.014 | 0.013 | 0.014 | Thyroid hormone alpha antagonist | |||
| 0.032 | 0.031 | 0.032 | Tubulin agonist | |||
| 0.162 | 0.161 | 0.162 | Calpain inhibitor | |||
| 0.009 | 0.008 | 0.009 | Progesterone receptor A antagonist | |||
| 0.016 | 0.015 | 0.023 | Telomerase stimulant | 0.023 0.005 CID_154699998 | CID_154699998 | |
| 0.02 | 0.02 | 0.031 | Dopamine D1 agonist | 0.031 0.008 CID_154699998 | CID_154699998 | |
| 0.03 | 0.031 | 0.06 | Arginase inhibitor | 0.06 0.01 CID_154699998 | CID_154699998 | |
| 0.07 | 0.071 | 0.089 | Interferon agonist | 0.089 0.039 CID_154699998 | CID_154699998 | |
| 0.112 | 0.115 | 0.247 | Diuretic | 0.247 0.031 CID_154699998 | CID_154699998 | |
| 0.053 | 0.056 | 0.07 | Lipocortins synthesis agonist | 0.07 0.021 CID_154699998 | CID_154699998 | |
| 0.019 | 0.031 | 0.025 | Uridine phosphorylase inhibitor | 0.025 0.022 CID_154699998 | CID_154699998 | |
| 0.043 | 0.067 | 0.099 | Neuraminidase inhibitor | 0.099 0.016 CID_154699998 | CID_154699998 | |
| 0.036 | 0.062 | 0.121 | Protein 50S ribosomal subunit inhibitor | 0.121 0.009 CID_154699998 | CID_154699998 | |
| 0.027 | 0.054 | 0.082 | Antibiotic Aminoglycoside-like | 0.082 0.004 CID_154699998 | CID_154699998 | |
| 0.088 | 0.12 | 0.336 | Cell adhesion inhibitor | 0.336 0.008 CID_154699998 | CID_154699998 | |
| 0.039 | 0.073 | 0.098 | Glucose-6-phosphate translocase inhibitor | 0.098 0.006 CID_154699998 | CID_154699998 | |
| 0.083 | 0.117 | 0.108 | Beta amyloid protein antagonist | 0.108 0.08 CID_154699998 | CID_154699998 | |
| 0.012 | 0.048 | 0.02 | Corticosteroid-like | 0.02 0.017 CID_154699998 | CID_154699998 | |
| 0.216 | 0.253 | 0.778 | Cyclophilin D inhibitor | 0.778 0.008 CID_154699998 | CID_154699998 | |
| 0.007 | 0.044 | 0.022 | Ileal bile acid transport inhibitor | 0.022 0.008 CID_154699998 | CID_154699998 | |
| 0.05 | 0.089 | 0.061 | Interferon inducer | 0.061 0.05 CID_154699998 | CID_154699998 | |
| 0.077 | 0.123 | 0.168 | Toll-Like receptor 4 antagonist | 0.168 0.013 CID_154699998 | CID_154699998 | |
| 0.034 | 0.09 | 0.38 | Selectin antagonist | 0.38 0.004 CID_154699998 | CID_154699998 | |
| 0.036 | 0.095 | 0.11 | Heparanase inhibitor | 0.11 0.004 CID_154699998 | CID_154699998 | |
| 0.002 | 0.062 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 CID_154699998 | CID_154699998 | |
| 0.033 | 0.094 | 0.073 | Alpha-mannosidase inhibitor | 0.073 0.015 CID_154699998 | CID_154699998 | |
| 0.016 | 0.083 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.018 CID_154699998 | CID_154699998 | |
| 0.021 | 0.088 | 0.071 | Phosphorylase inhibitor | 0.071 0.02 CID_154699998 | CID_154699998 | |
| 0.036 | 0.105 | 0.078 | Nitric oxide donor | 0.078 0.024 CID_154699998 | CID_154699998 | |
| 0.026 | 0.102 | 0.05 | Microtubule stabilization | 0.05 0.028 CID_154699998 | CID_154699998 | |
| 0.021 | 0.107 | 0.063 | Mannosidase inhibitor | 0.063 0.015 CID_154699998 | CID_154699998 | |
| 0.035 | 0.128 | 0.051 | Factor III inhibitor | 0.051 0.032 CID_154699998 | CID_154699998 | |
| 0.058 | 0.159 | 0.147 | Transcription factor NF kappa B stimulant | 0.147 0.016 CID_154699998 | CID_154699998 | |
| 0.07 | 0.174 | 0.328 | Thrombolytic | 0.328 0.02 CID_154699998 | CID_154699998 | |
| 0.035 | 0.141 | 0.07 | DNA gyrase inhibitor | 0.07 0.035 CID_154699998 | CID_154699998 | |
| 0.085 | 0.243 | 0.291 | Hypolipemic | 0.291 0.052 CID_154699998 | CID_154699998 | |
| 0.041 | 0.237 | 0.146 | Cell adhesion molecule inhibitor | 0.146 0.016 CID_154699998 | CID_154699998 | |
| 0.015 | 0.232 | 0.05 | Neuraminidase (Influenza A) inhibitor | 0.05 0.023 CID_154699998 | CID_154699998 | |
| 0.014 | 0.243 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CID_154699998 | CID_154699998 | |
| 0.021 | 0.288 | 0.092 | Factor IXa inhibitor | 0.092 0.012 CID_154699998 | CID_154699998 | |
| 0.035 | 0.333 | 0.076 | Falcipain 2 inhibitor | 0.076 0.075 CID_154699998 | CID_154699998 | |
| 0.035 | 0.34 | 0.078 | Falcipain inhibitor | 0.078 0.077 CID_154699998 | CID_154699998 | |
| 0.042 | 0.404 | 0.28 | Platelet antagonist | 0.28 0.06 CID_154699998 | CID_154699998 | |
| 0.042 | 0.633 | 0.381 | Immunomodulator | 0.381 0.05 CID_154699998 | CID_154699998 | |
| 0.009 | 0.719 | 0.184 | Anticoagulant | 0.184 0.06 CID_154699998 | CID_154699998 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |